administering the anitiviral, remdesivir, to adults hospitalised with Covid-19 lower respiratory tract infection, shortened the time to recovery by 4 days.
The United States Centers for Disease Control and Prevention (US CDC) cited several evidences to show to the COVID-19 outbreak commenced in the country between mid-January and early February.